A randomized controlled trial with an anti‐CCL2 (anti–monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis

Jasper J. Haringman, Paul P. Tak, Barry Bresnihan et al.|Arthritis & Rheumatism|2006

Cited by 255